Neural mechanisms of parasite-induced summiting behavior in ‘zombie’ Drosophila

  1. Carolyn Elya  Is a corresponding author
  2. Danylo Lavrentovich
  3. Emily Lee
  4. Cassandra Pasadyn
  5. Jasper Duval
  6. Maya Basak
  7. Valerie Saykina
  8. Benjamin de Bivort  Is a corresponding author
  1. Department of Organismic and Evolutionary Biology, Harvard University, United States
7 figures, 1 table and 4 additional files

Figures

Figure 1 with 2 supplements
Behavioral signature of E.muscae-induced summiting in wild-type flies.

(A) E. muscae-killed fruit flies that summited on a wooden dowel prior to death. (B) Timeline of events relative to an E. musace-infected fly’s last movement (dashed line). See (Elya et al., 2018; Krasnoff et al., 1995). (C) Summiting assay schematic. (D) Example y position data for a typical survivor fly (top) and zombie (bottom). X-axis is Zeitgeber time (ZT), hours since lights were turned on. The fly ‘skull’ indicates the manually-annotated time of zombie death (see Methods). Black and yellow bars indicate the state of visible illumination. (E) Distribution of time of death for Canton-S flies killed by E. muscae. Background color indicates the state of visible illumination. (F) Mean y position (middle) and mean speed (bottom) of survivor flies (blue) and zombie flies (red) housed in arenas angled at 30° with food at the bottom (schematic at top) during the 12 hr preceding the time of death. Here and in all other panels, shaded regions are +/− 1 standard error of the mean. Time of death for zombies was manually determined as the time of the last movement from the y position trace. Survivors did not die but were assigned fictive times of death from the distribution of zombie death times for comparability (see Methods). (G) As in (F), but comparing zombies in standard arenas (30° with respect to gravity, same data as (F); solid lines) to zombies in flat arenas (0°; dashed lines). (H) As in (F) and (G), but comparing zombies in standard arenas (food at the bottom, same data as (F); solid lines) to zombies in arenas with food at the top (dashed lines). (I) Speed versus time for three examples Canton-S zombies (left) and their corresponding summit metrics (middle) outlined in black (right) amidst all Canton-S summit metrics (N=555, right). Black circles denote the window of summiting behavior as determined from the mean behavior of Canton-S zombie flies. Dashed red line indicates the mean speed in the hour preceding summiting (baseline speed). Summit metric is calculated as the integral of speed minus baseline in the summiting window (shaded region). (J) Relative y position change versus summit metric for Canton-S zombies (N=555). Points are individual flies. Linear regression line in black; Pearson’s correlation r & p-value (upper left).

Figure 1—figure supplement 1
E.muscae-infected flies die at specific times of day in the absence of proximal lighting cues.

Distributions of time of death for Canton-S flies killed by E. muscae with (A) continuous L:D cues, (B) L:D cues terminating after 96 hr, or (C) L:D cues terminating after 72 hr. Background color indicates state of visible illumination (black or gray = no light; yellow = light; gray = entrainment conditions). Time of death for zombies was manually determined as the time of the last movement from the y position trace. Number of total cadavers observed in each panel is indicated in top right.

Figure 1—figure supplement 2
Additional features of summiting behavior in the custom behavior assay.

(A) Unexposed, wild-type flies that die of starvation do not exhibit a burst in activity beginning 2.5 hr prior to their last movement, and (C) do not exhibit specific circadian timing of death. Flies in this experiment were provided with non-nutritive agar instead of food at position y = 0. (B) Unexposed, wild-type flies that die of desiccation do not exhibit a burst in locomotor activity beginning 2.5 hr prior to their last movement, and (D) do not exhibit specific circadian timing of death. Flies in this experiment were provided food nor agar at position y = 0. (E) Mean y position of zombie flies diverges from survivors beginning around 24 hr prior to death when nutritive food is positioned at y = 1. (F) Compared to survivors, zombie flies prefer nutritive (5% sucrose, 1.5% agar) over non-nutritive (0% sucrose, 1.5% agar) media in their final 12 hours of life prior to the onset of summiting at 2.5 hours before death. (G) Zombie flies housed on non-nutritive food for their final 24 hr do not exhibit summiting behavior and (H) show typical timing of last death (compare to Figure 1E). (I) When housed in tall arenas (13 cm) with food placed in the middle, zombie flies tend to move slightly upward when the arena is tilted at 30°, but not 0°. Zombies in arenas at both angles exhibit a burst of speed prior to death (bottom). (J, K) Summit metric (see Figure 1I) does not vary for zombies housed in chambers at 0° versus 30° in tall or standard chambers. (L) Summit metric for female versus male Canton-S zombies. (M) Distribution of estimated effect size of sex on summiting. For (A, B, E-K), diagrams depicting behavior arena setup are shown above corresponding plots. For L and M, behavior arenas were in standard configuration (as in Figure 1F)* = p<0.05; **=p<0.01; *** p<0.001 by two-tailed t-test.

Figure 2 with 2 supplements
Identification of host circuits and genetic components involved in summiting behavior.

(A) Regions and pathways targeted in the candidate screen. AMMC = antennal mechanosensory and motor center; CX = central complex; SOG = subesophageal ganglion; MB = mushroom body; NM & NT = neuromodulator or neurotransmitter; NP = neuropeptide; PI = pars intercerebralis. (B and C) Effects of neuronal disruption (B; 12<N<111, median N=35) or gene knockdown or mutagenesis (C; 10<N<182, median N=46) on summiting. Above: Summiting effect size estimate distributions as estimated by bootstrapping. Experimental groups are ordered by mean effect (negative to positive). Below: gene function and brain region annotations associated with each screened reagent. See Supplementary file 1 for genotype and annotation details. Solid gray line indicates an effect size of zero. Dashed vertical lines separate ranked data into quintiles. (D and E) Frequency of annotations by quintile for (B) and (C), respectively. The number of lines screened (N) is indicated for each annotation. Dashed line indicates the frequency of annotation expected from a null, uniform distribution. Black arrowheads highlight annotations that are overrepresented in the first quintile. For (D), pink overlays indicate the portion of line annotations that are co-annotated for expression in the PI. (F and G) Summiting effect size estimate distributions of disrupting specific circadian genes (F; 19<N<182, median N=62) or circadian and/or PI neurons (G; 11<N<111, median N=46) compared to genotype-matched controls. Lines are ordered by effect size. Pink indicates Gal4 expression in the PI, lime circadian Gal4 lines and genes, and black outlines expression only in DN1ps. Asterisks indicate statistically significant effects on summiting behavior by a two-tailed t-test (*=p<0.05; **=p<0.01; *** p<0.001). R19G10 is highlighted in pink to emphasize its subsequent use as the main PI reagent. See Supplementary file 2 for genotypes and matched controls. (H) Maximum z-projections of brains showing pre- (synaptotagmin; syt-eGFP) and post- (DenMark) synaptic compartments of R19G10 neurons. Bruchpilot (nc-82) staining (blue) visualizes neuropil. Above: brain imaged from anterior. Below: another brain, imaged from the posterior. (I and J) Mean speed of unexposed flies vs time for Clk4.1>TrpA1 and R19G10>TrpA1 genotypes and sibling controls, respectively. Shaded regions are +/− 1 standard error of the mean. Bars along the x-axis indicate the state of visible illumination (above) and temperature (below). (K) Red light onset-triggered mean speed across flies of unexposed R19G10>CsChrimson flies versus time. All trans retinal (ATR) indicates control flies not fed CsChrimson cofactor. Shaded regions are +/− 1 standard error of the mean. Bar along the x-axis indicates lighting conditions (black: darkness, red: red-light illumination).

Figure 2—figure supplement 1
Additional experiments assessing summiting after clock neuron and R19G10 disruption.

(A–C) Plots visualizing summiting for manipulations targeting R19G10 and DN1p neurons. Top: Mean zombie baseline-corrected speed versus time. Shaded area is +/− 1 standard error. Bottom: Individual SM (circles) and median SM (line). *=p<0.05; **=p<0.01; ***p<0.001 by two-tailed t-test. Clk4.1 drives expression in 8–10 and R18H11 drives expression in 7–8 of DN1p neurons per hemisphere, respectively (Kunst et al., 2014; Zhang et al., 2010). (D) Left: Summiting effect size estimate distributions for Gal4/effector combinations targeting clock neurons. Sample size of experimental animals is in black, and controls in gray. Right: Diagrams depicting target cells of tested reagents following Shafer et al., 2022. Violin plot outline colors match diagrams. *=p<0.05; **=p<0.01; ***p<0.001 by two-tailed t-test. (E) Confocal micrographs demonstrating ablation of Pdf-expressing neurons in Pdf-Gal4>hid animals. (F) Summiting effect size estimate distributions when targeting components of the circadian locomotor output pathway identified by Cavanaugh et al., 2014. *=p<0.05; **=p<0.01; ***p<0.001 by two-tailed t-test.

Figure 2—figure supplement 2
Additional experiments assessing the sufficiency of DN1p and R19G10 neuron activation for increased locomotion.

(A–D) Mean speed of unexposed flies with thermogenetically activated DN1p or R19G10 neurons (solid line) versus sibling controls (dashed line) separated by sex. The presence or absence of light is indicated below the horizontal axis with a yellow or black bar, respectively. The measured temperature of the room is shown as a heat map below the light cue indicator. Shaded regions are +/− 1 standard error. For A and B, Clk4.1-Gal4 was used to drive expression in DN1ps. (E and F) Kernel density estimates of the distribution of log-speed for R19G10 >CsChrimson flies with (F) or without (E) of dietary all trans retinal (ATR) in the presence of absence of 5 Hz pulsed red light stimulus (OFF and ON, respectively). A bimodal distribution of speeds is observed regardless of ATR and light treatment. The lower peak (centered around 0) corresponds to non-walking and the higher peak (centered around 6mm/s) corresponds to walking flies. (G) Mean speed across flies of unexposed R19G10>CsChrimson flies before and after the second presentation of red light in the experiment described in Figure 2K. ATR+ flies show a smaller increase in locomotion upon red light stimulus, consistent with CsChrimson depolarization block or adaptation within the stimulated circuit.

Figure 3 with 2 supplements
R19G10 (PI-CA) neurons project to the corpora allata, which are required for summiting behavior.

(A) Left: Composite micrograph of dissected Aug21>GFP fly, showing GFP fluorescence in the corpora allata (CA) overlaid on bright field image. Right: Diagram of A with anatomical features labeled. PV = proventriculus. (B) Representative confocal micrograph of immunostained RC from an R19G10>syt-eGFP, DenMark fly. Synaptic terminals are visible as green puncta, including in the CA. Magenta is anti-JHAMT and marks the CA. Blue phalloidin counterstain marks actin. Labels as in A. (C) Summiting effect size estimate distribution of ablating the CA with diphtheria toxin (DTI). Effect size is calculated relative to effector-less sibling controls. (D) Representative micrographs of CA-ablated and effector-less, sibling, temperature-matched control flies (additional examples in Figure 3—figure supplement 1D). White arrows indicate the expected location of CA. e = eye, p = proboscis. (E) Summiting effect size estimate distributions of various concentrations of the CA-ablating drug precocene. Effect size is calculated relative to vehicle (acetone) control. For (C and E), effect sizes were estimated as in Figure 2; asterisks indicate statistically significant effects (*=p<0.05; **=p<0.01; ***p<0.001) by two-tailed t-test. Sample sizes of experimental and control experiments are given in black and gray, respectively.

Figure 3—figure supplement 1
Supporting data for juvenile hormone involvement in summiting.

(A) Summiting effect size estimate distribution for Akh- mutants, showing no effect compared to controls. Sample size of experimental animals is in black, and controls in gray. *=p<0.05; **=p<0.01; ***p<0.001 by two-tailed t-test. (B) As in (A) for the ablation of the corpora allata (CA) using NiPP1 effector (per Yamamoto et al., 2013). A significant reduction in summiting is seen compared to controls. (C) Confocal micrographs of the anterior foregut and retrocerebral complexes from Aug21>GFP, NiPP1 flies, and Aug21>GFP sibling controls. Green channel is GFP and magenta anti-actin phalloidin counterstain. Arrowheads indicate the observed or expected location of CA. Scale bar is 100 microns. CAs in Aug21>GFP, NiPP1 animals ranged from intact to absent. (D) Compound epifluorescence micrographs of the head, anterior foregut, and retrocerebral complexes of tub-Gal80, Aug21> GFP, DTI flies. In animals in which DTI expression was induced by thermal inactivation of the Gal80 repressor, only one sample showed potential residual CA; all other animals lacked CA.CA were observed in all controls. e = eye, p = proboscis.

Figure 3—figure supplement 2
Additional experiments examining juvenile hormone involvement in summiting.

(A) Synthesis pathway for juvenile hormone. Enzymes catalyzing each step are shown at right. HMG-CoA reductase (blue) is the target of the drug fluvastatin. (B) Summiting effect size estimate distribution for E. muscae-exposed flies fed with fluvastatin (250 µg/well) starting 72 hr after exposure to E. muscae. *=p<0.05; **=p<0.01; ***p<0.001 by two-tailed t-test. Sample size of experimental animals is in black, and controls in gray. (C) Times of death for flies fed fluvastatin 72 hr after exposure and killed by E. muscae (i.e. with sporulation). (D) Stacked bar plots of survival outcomes for fluvastatin-treated flies and controls, at 72 hr and 24 hr after E. muscae exposure. Flies were manually assessed as alive or dead at the end of behavior tracking; dead flies were further classified as having sporulated (Sp+) or not (Sp−). E. muscae-exposed N = 91–108; unexposed N=20–37. (E) Times of death for flies fed fluvastatin 24 hr after exposure, which showed no signs of sporulation and died roughly uniformly throughout the day. (F) Stacked bar plots of survival outcomes for flies treated topically with the indicated amount of precocene or vehicle control (acetone) with or without exposure to E. muscae. E. muscae-exposed N = 97–100; unexposed N = 28–31. (G) Times of death for flies exposed to E. muscae and treated with three concentrations of precocene or acetone at 72 hr after exposure. (H) Summiting effect size estimate distributions for topical application of the JH analog methoprene at two different doses. This had no effect compared to vehicle (acetone) controls. (I) Summiting effect size estimate distributions for co-applied methoprene or dietary pyriproxyfen. These treatments did not rescue summiting deficits induced by precocene.

Figure 4 with 1 supplement
A random-forest classifier (RFC) for identifying summiting flies in real-time.

(A) Top: classes learned by the classifier for zombies were pre-summiting=prior to the onset of summiting (yellow), during summiting = after the onset of summiting but before the time of death (red), and post-summiting=after the time of death (black). For survivors, there was one class, never-summiting (blue). Bottom: annotations of these classes on example y position trajectories from a survivor (left) and zombie (right). (B) Feature vectors (Xt) generated for 200 random time points (t) for each fly. Vertical green and pink lines in the example trajectory below indicate the historical (green) and recent (pink) values selected for the feature vector. (C) Feature importance for classification of the 61 input variables. Roman numerals correspond to plots in subsequent panels. (D) Distributions of important feature variables, visualized with kernel density estimation, across never summiting (blue), pre-summiting (yellow), and summiting (red) classes within the training dataset. (E) Confusion matrices for precision (left) and recall (right) performance of the classifier on the test dataset. (F) Confusion matrix for the survivor and zombie outcomes after implementing the real-time zombie-calling criterion. (G) Example real-time behavior and class probability trajectories for a zombie fly, ending on the frame when it was called as a zombie. (H) Summarized experimental workflow using the real-time classifier.

Figure 4—figure supplement 1
Development of a real-time random forest classifier for summiting behavior.

(A) Confusion matrices calculated using the validation dataset (25% of the total ground truth data). (B) Example classifications of a summiting (zombie) and a non-summiting (survivor) fly over an entire behavior-tracking experiment. Top and middle plots for each example are the fly’s y position and speed; bottom plot is the class probabilities for the fly at each timepoint. In the summiting example, the fly is consistently classified as pre-summiting (i.e. will become a zombie before the next occurrence of the sunset) starting as early as ZT22 the evening prior to death. This fly was classified as summiting from approximately ZT9.25 to ZT10.75 the following day, and post-summiting (i.e. dead) ZT11 onward. In contrast, the non-summiting example fly was consistently classified as never-summiting (i.e. would live through the next sunset) for the duration of the experiment.

Figure 5 with 1 supplement
E.muscae densely occupies the superior medial protocerebrum (SMP) during summiting without apparent degradation of pars intercerebralis to corpora allata (PI-CA) neurons or corpora allata (CA).

(A) Confocal micrographs of the superior medial protocerebrum (SMP) from summiting His-RFP fly. Non-fly nuclei (Hoechst+, HisRFP−) are large compared to fly neuronal nuclei (Hoechst+, HisRFP+) and sit in ‘holes’ in the neuropil visible in the nc82 counterstain channel. Scale bar is 20 microns. (B) Whole brain invasion pattern of E. muscae (same brain as A). Nuclei are colored according to depth from anterior (A) to posterior (P). (C) Distribution of fungal nuclei across brain regions (N=3). AL = antennal lobe, SIP = superior intermediate protocerebrum, SLP = superior lateral protocerebrum, CX = central complex, VLP = ventrolateral protocerebrum, SOG = subesophageal ganglion, LO = lobula, ME = medulla, midline = cells along the midline of the brain not in any other region. (D) Confocal micrographs of PI-CA neurons (green) and phalloidin counterstain (magenta) in control and summiting flies. Left: sagittal planes of the central brain. Holes are apparent (in the phalloidin channel) in the SMP of the summiting brain, marked by arrowheads in one hemisphere. Holes are absent in CX of summiting brains and all control brain regions. Middle: Inset from the left. Right: Maximum z-projections of GFP channel from full brain z-stacks. PI-CA morphology appears the same in summiting and control brains. Scale bars are 50 microns. (E) Counts of PI-CA cell bodies in control (unexposed), summiting, or recently-killed (cadaver) PI-CA >mcd8 GFP flies (** indicates p<0.01 by a two-tailed t-test). (F) Distribution of ‘holes’ across brain regions. Abbreviations as in C. (G) Safranin and fast green stained sections of paraffin-embedded Canton-S flies. Left: Infected, non-summiting fly (96 hr after exposure to fungus). Right: summiting, E. muscae-infected fly. a=abdomen, b=brain, w=wing, m=muscle. Scale bars are 200 microns. Insets of the abdomen and brain are shown for each fly below (scale bars are 25 microns). Host tissues are outlined in dashed black; black arrowheads indicate fungal nuclei. (H) Micrographs of dissected abdomens of 96-hour post-exposure non-summiting (left) and summiting (right) female flies. Gut and reproductive organs are still present in the non-summiting fly, but are absent in the summiting fly. Clumps of spherical fungal cells are visible in the dissection saline of summiting but not non-summiting fly. (I) Fluorescence images of dissected Aug21 >GFP flies. White arrowheads indicate CA. p=proboscis, e=eyes. Scale bars are 100 microns. Additional examples are available in Figure 5—figure supplement 1F.

Figure 5—figure supplement 1
Supporting data for host morphology during E.muscae infection.

(A) Confocal micrographs of five infected brains 72 hr after E. muscae exposure. Green is Hoechst and marks all nuclei. Magenta is the synaptic marker nc82. Fungal cells are present in the SMP and absent from the central complex (CX). Scale bar is 50 microns. (B) Confocal micrographs if PI-CA>mcd8GFP (green) brains during summiting and unexposed to E muscae. White arrowheads indicate apparent displacement of pars intercerebralis to corpora allata (PI-CA) processes by fungal cells. Scale bar=25 microns. (C) Distribution of E. muscae nuclei across brain regions from a whole-brain confocal volume (2-micron z-step), using two counting methods. Counting every nucleus seen in a single z-slice as one cell (‘Raw counts’), and merging cell bodies if they have the same x- and y-position (to within 2 µm) and appear within 10 microns of each other along the z-axis (‘Collapsed counts’) produces very similar distribution estimates (N=1,426 nuclei). (D) Z-projections of nuclei as counted by the Raw and Collapsed methods. (E) Micrographs of dissected summiting Aug21>GFP fly. Top: Head (brightfield overlaid with GFP channel). White arrow points to the corpora allata (CA). Bottom: Abdomen (brightfield) with ventral cuticle peeled back. Dashed line indicates the edges of the fly’s remaining cuticle. Only fungal tissues and no host organs are visible inside the dashed line. (F) Additional whole-mount preparations of Aug21>GFP heads and retrocerebral complexes in control (non-summiting) and summiting flies, as in Figure 5. White arrows indicate CA; p=proboscis, e=eyes. Scale bars each 100 microns.

Figure 6 with 2 supplements
Hemolymph of summiting flies has a distinct metabolome and induces locomotion.

(A) Blood-brain barrier (BBB) permeability of E. muscae exposed (96 hr) or unexposed flies assessed as the portion of flies with eye fluorescence after Rhodamine B (RhoB) injection (N=40–50 per group). Infected (doomed) flies are exposed flies with fungal growth visible by the eye through the abdominal cuticle, all of whom would go on to summit within 22 hr. Bright-eyed flies (+) had visible RhoB uptake. Representative brains from dim and bright-eyed flies are shown at right. (B) Volcano plot of hemolymph metabolites detected by LC-MS mass spectrometry in summiting (S) versus exposed, non-summiting (NS) flies. Putative identifications are given for selected compounds. See Supplementary file 3 for compound abundances and statistical details. (C and D) Total distance traveled versus time for flies receiving a transfusion of hemolymph from summiting donors. Diagrams at the top indicate the hemolymph transfusion experiment configuration. Shaded areas indicate +/− 1 standard error. Asterisks indicate p-values <0.05 for two-tailed t-tests performed at each timepoint.

Figure 6—figure supplement 1
Blood-brain permeability as a function of time since exposure.

Flies were injected with 1.44 mg/mL Rhodamine B (RhoB) and then allowed to incubate for four hours prior to scoring eye fluorescence. Experimenters were blind to treatment type. Error bars are the estimated standard error of the binomial proportion. Background shading indicates entrained lighting conditions experienced by all flies (yellow = lights on, gray = lights off).

Figure 6—figure supplement 2
Metabolomics of summiting flies.

(A) Compounds of interest from classifier-staged metabolomics experiment. Compounds are included if at least one of three conditions is met: (1) they are significantly different between summiting and non-summiting, exposed animals, and exhibit at least a twofold change between these treatments, (2) they were only detected in summiting flies (‘Summiting only’), or (3) they were only detected in exposed flies (‘Exposed only’; summiting or non-summiting), but not unexposed flies. p-values <0.05 are highlighted in yellow. Compounds highlighted in green were observed to be significantly different between summiting and non-summiting flies in both the manual and classifier-based experiments (p< = 0.05 by a two-tailed t-test); compounds in blue were significant in the classifier-staged experiment and fell just short of significant (p<0.08) in the manual experiment. (B) Scatter plot of the log2-fold-change of compound abundance in summiting compared to unexposed flies versus the log2-fold-change of compound abundance in summiting compared to exposed, non-summiting flies. Data from the classifier-staged experiment. Compounds in the darkest red were observed only to have chromatogram peaks above baseline (1e3 intensity counts) in summiting samples and not in any other samples. Compounds in medium red were only observed to have real peaks in exposed (summiting or non-summiting) but not unexposed samples across both experiments. Compounds in light red were observed in all experimental groups of both experiments (molecular weight within five parts per million between experiments). Compounds in white were observed in the classifier-based experiment but were not observed in the manually-staged experiment (absolute difference in molecular weight greater than five ppm). Compounds that were observed in both experiments, showed significant differences between summiting and non-summiting flies, and were tentatively identified, are labeled with the compound name or molecular formula. (C) As in (B), for the manually staged experiment. (D,E) Raw chromatogram peaks for three compounds assessed to only be present in summiting flies in manually-staged (D) and classifier-staged (E) metabolomics experiments. Different peaks of the same color are biological replicates. Putative formulas as determined from the measured mass given in the upper left corner for each plot.

Figure 6—figure supplement 2—source data 1

Compounds over- or under-abundant in the hemolymph of summiting flies from classifier-staged metabolomics experiment.

https://cdn.elifesciences.org/articles/85410/elife-85410-fig6-figsupp2-data1-v2.xlsx
Proposed sequence of E.muscae-induced summiting mechanisms in zombie flies.

(A) Events in the host brain leading to E. muscae-induced summiting. (1) E. muscae cells are present in the brain as soon as 48 hr prior to death (Elya et al., 2018). (2) By 24 hr prior to death, the fungus is present at a high density in the superior medial protocerebrum (SMP). This corresponds to the ‘infected (doomed)’ status of flies in Figure 6. (3) E. muscae alters the hemolymph (perhaps by secreting compounds, as depicted here) to trigger the onset of summiting behavior. (4) Hemolymph-borne factors alter the activity of the circadian network/DN1p and pars intercerebralis to corpora allata (PI-CA) neurons. (5) Juvenile hormone (JH) is released from the corpora allata (CA) following changes in PI-CA activity. (6) Increased JH levels drive an increase in locomotion. The dashed outline of the brain becomes more prominent between steps 1 and 3 to reflect an increase in blood-brain barrier (BBB) permeability over these timepoints. (B) Left: Timeline of events depicted in (A) overlaid on cartoon plot of average relative y position (above) and speed (below) for zombie flies. Summiting is indicated by a black star; death (time of the last movement) is indicated by a fly ‘skull.’ Right: Zombie flies summited on a wooden dowel.

Tables

Key resources table
Reagent type (species) or resourceDesignationSource or referenceIdentifiersAdditional information
antibodyanti-Chicken-AF488 (goat polyclonal)Thermo FisherCat#: A-11039, RRID:AB_2534096IF(1:800)
antibodyanti-dsRed (rabbit polyclonal)Takara BioCat#: 632496, RRID:AB_10013483IF:(250)
antibodyanti-GFP (chicken polyclonal)Aves LabsCat#: GFP-1020, RRID:AB_10000240IF(1:4000)
antibodyanti-Guinea Pig-AF568 (goat polyclonal)Thermo FisherCat#: A-11075, RRID:AB_2534119IF(1:400)
antibodyanti-JHAMT (guinea pig polyclonal)Niwa et al., 2008IF(1:1000)
antibodyanti-Mouse-Cy5 (goat polyclonal)MilliporeCat#: AP500S, RRID:AB_805361IF(1:400)
antibodyanti-nc82 (mouse monoclonal)Iowa Developmental Studies Hybridoma BankCat#: nc82, RRID:AB_2314866IF(1:40)
antibodyanti-Rabbit-AF568 (goat polyclonal)Thermo FisherCat# A-11011, RRID:AB_143157IF(1:250)
genetic reagent (D. melanogaster)104y-Gal4Bloomington Drosophila Stock CenterBDSC:81014
genetic reagent (D. melanogaster)104y-Gal4; Cha-Gal80Derived from BDSC:81014 & Cha-Gal80
genetic reagent (D. melanogaster)acj6-Bloomington Drosophila Stock CenterBDSC:30025
genetic reagent (D. melanogaster)acj6-Gal4Bloomington Drosophila Stock CenterBDSC:30025
genetic reagent (D. melanogaster)Akh-Bloomington Drosophila Stock CenterBDSC:84448
genetic reagent (D. melanogaster)AstC-Bloomington Drosophila Stock CenterBDSC:84453
genetic reagent (D. melanogaster)Bl/CyO; tub-Gal80(ts)Kristin Scott
(McGuire et al., 2004)
genetic reagent (D. melanogaster)C(1)Dxyfv(X^X)/Y; Aug21-Gal4, UAS-GFP/CyORochele Yamamoto (Yamamoto et al., 2013)
genetic reagent (D. melanogaster)c17-Gal4Bloomington Drosophila Stock CenterBDSC:39690
genetic reagent (D. melanogaster)c41-Gal4Bloomington Drosophila Stock CenterBDSC:30834
genetic reagent (D. melanogaster)c708a-Gal4Bloomington Drosophila Stock CenterBDSC:50743
genetic reagent (D. melanogaster)Canton-SLiming Wang
genetic reagent (D. melanogaster)CCha1-Bloomington Drosophila Stock CenterBDSC:84458
genetic reagent (D. melanogaster)CCKR-17D1-Bloomington Drosophila Stock CenterBDSC:84462
genetic reagent (D. melanogaster)CCLKR-17D3-Bloomington Drosophila Stock CenterBDSC:84463
genetic reagent (D. melanogaster)Cha-Gal80/TM3, SbToshihiro Kitamoto
(Kitamoto, 2002)
genetic reagent (D. melanogaster)Clk4.1-Gal4Bloomington Drosophila Stock CenterBDSC:36316
genetic reagent (D. melanogaster)Clk4.5-Gal4Bloomington Drosophila Stock CenterBDSC:37526
genetic reagent (D. melanogaster)Clk856-Gal4/CyO; 911-QF, QUAS-FLP/TM6, SbDavid Cavanaugh
(Nettnin et al., 2021)
genetic reagent (D. melanogaster)Clk856-Gal4/CyO; MKRS/TM6BDaniel Cavanaugh (Gummadova et al., 2009)
genetic reagent (D. melanogaster)ClkarBloomington Drosophila Stock CenterBDSC:24513
genetic reagent (D. melanogaster)ClkJrkBloomington Drosophila Stock CenterBDSC:24515
genetic reagent (D. melanogaster)CloutBloomington Drosophila Stock CenterBDSC:56754
genetic reagent (D. melanogaster)CNMa-Bloomington Drosophila Stock CenterBDSC:84485
genetic reagent (D. melanogaster)CNMaR-Bloomington Drosophila Stock CenterBDSC:84486
genetic reagent (D. melanogaster)cry-Gal4.Z16Bloomington Drosophila Stock CenterBDSC:24514
genetic reagent (D. melanogaster)cry-Gal4.Z24Bloomington Drosophila Stock CenterBDSC:24774
genetic reagent (D. melanogaster)cry02Bloomington Drosophila Stock CenterBDSC:86267
genetic reagent (D. melanogaster)crybBloomington Drosophila Stock CenterBDSC:80921
genetic reagent (D. melanogaster)cyc01Bloomington Drosophila Stock CenterBDSC:80929
genetic reagent (D. melanogaster)DAT-Bloomington Drosophila Stock CenterBDSC:25547
genetic reagent (D. melanogaster)Dh31-Bloomington Drosophila Stock CenterBDSC:84490
genetic reagent (D. melanogaster)Dh31KG09001Bloomington Drosophila Stock CenterBDSC:16474
genetic reagent (D. melanogaster)DH31R-Bloomington Drosophila Stock CenterBDSC:84491
genetic reagent (D. melanogaster)disco1Bloomington Drosophila Stock CenterBDSC:5682
genetic reagent (D. melanogaster)DNc01Janelia Research CenterJRC:SS04161
genetic reagent (D. melanogaster)DNc02Janelia Research CenterJRC:SS02395
genetic reagent (D. melanogaster)DNp01Janelia Research CenterJRC:SS00726
genetic reagent (D. melanogaster)DNp01Janelia Research CenterJRC:SS00727
genetic reagent (D. melanogaster)DNp01Janelia Research CenterJRC:SS02299
genetic reagent (D. melanogaster)Dsk-Bloomington Drosophila Stock CenterBDSC:84497
genetic reagent (D. melanogaster)elav-Gal4; UAS-Dcr2Bloomington Drosophila Stock CenterBDSC:25750
genetic reagent (D. melanogaster)forSBloomington Drosophila Stock CenterBDSC:76120
genetic reagent (D. melanogaster)fru-Gal4Bloomington Drosophila Stock CenterBDSC:30027
genetic reagent (D. melanogaster)GH86-Gal4Bloomington Drosophila Stock CenterBDSC:36339
genetic reagent (D. melanogaster)gl60jBloomington Drosophila Stock CenterBDSC:509
genetic reagent (D. melanogaster)GLSNP3375-Gal4Kyoto Drosophila Stock CenterKDSC:104479
genetic reagent (D. melanogaster)His-RFPBloomington Drosophila Stock CenterBDSC:23651
genetic reagent (D. melanogaster)Hug-Gal4Bloomington Drosophila Stock CenterBDSC:58769
genetic reagent (D. melanogaster)iav-Gal4Bloomington Drosophila Stock CenterBDSC:52273
genetic reagent (D. melanogaster)Ilp1-Gal4Bloomington Drosophila Stock CenterBDSC:66005
genetic reagent (D. melanogaster)Ilp2-Gal4Bloomington Drosophila Stock CenterBDSC:37516
genetic reagent (D. melanogaster)Ilp3-Gal4Bloomington Drosophila Stock CenterBDSC:52660
genetic reagent (D. melanogaster)Ilp5-Gal4Bloomington Drosophila Stock CenterBDSC:66008
genetic reagent (D. melanogaster)JO-ACE-Gal4Kyoto Drosophila Stock CenterKDSC:113902
genetic reagent (D. melanogaster)JO-CE-Gal4Kyoto Drosophila Stock CenterKDSC:113878
genetic reagent (D. melanogaster)JO15-Gal4Bloomington Drosophila Stock CenterBDSC:6753
genetic reagent (D. melanogaster)Kurs58-Gal4Bloomington Drosophila Stock CenterBDSC:80985
genetic reagent (D. melanogaster)MB010B-Gal4Janelia Research CenterJRC:MB010B
genetic reagent (D. melanogaster)Mmp2NP0509-Gal4Kyoto Drosophila Stock CenterKDSC:103625
genetic reagent (D. melanogaster)nan-Gal4Bloomington Drosophila Stock CenterBDSC:24903
genetic reagent (D. melanogaster)nan36aKristin Scott
(Kim et al., 2003)
genetic reagent (D. melanogaster)NPF-Bloomington Drosophila Stock CenterBDSC:84549
genetic reagent (D. melanogaster)Oamb-Bloomington Drosophila Stock CenterBDSC:22758
genetic reagent (D. melanogaster)OctBeta1R-Bloomington Drosophila Stock CenterBDSC:18589
genetic reagent (D. melanogaster)Octbeta2R-Bloomington Drosophila Stock CenterBDSC:18896
genetic reagent (D. melanogaster)OctBeta3R-Bloomington Drosophila Stock CenterBDSC:24819
genetic reagent (D. melanogaster)Pdf-Bloomington Drosophila Stock CenterBDSC:84561
genetic reagent (D. melanogaster)Pdf-Gal4Bloomington Drosophila Stock CenterBDSC:6899
genetic reagent (D. melanogaster)Pdf-Gal80, cry24-Gal4Bloomington Drosophila Stock CenterBDSC:80940
genetic reagent (D. melanogaster)Pdf01Bloomington Drosophila Stock CenterBDSC:26654
genetic reagent (D. melanogaster)PdfR-Bloomington Drosophila Stock CenterBDSC:84705
genetic reagent (D. melanogaster)PdfR-; DH31R-Derived from BDSC:84705 & BDSC:84491
genetic reagent (D. melanogaster)PdfR-Gal4Bloomington Drosophila Stock CenterBDSC:68215
genetic reagent (D. melanogaster)PdfR5304Bloomington Drosophila Stock CenterBDSC:33068
genetic reagent (D. melanogaster)per-Gal4Bloomington Drosophila Stock CenterBDSC:7127
genetic reagent (D. melanogaster)per01Bloomington Drosophila Stock CenterBDSC:80928
genetic reagent (D. melanogaster)per30Bloomington Drosophila Stock CenterBDSC:63136
genetic reagent (D. melanogaster)perSBloomington Drosophila Stock CenterBDSC:80919
genetic reagent (D. melanogaster)ple-Gal4Bloomington Drosophila Stock CenterBDSC:8848
genetic reagent (D. melanogaster)Procc04750Bloomington Drosophila Stock CenterBDSC:11587
genetic reagent (D. melanogaster)ProcMI06590Bloomington Drosophila Stock CenterBDSC:42407
genetic reagent (D. melanogaster)ProcRMB00909Bloomington Drosophila Stock CenterBDSC:22930
genetic reagent (D. melanogaster)R10F08-Gal4Bloomington Drosophila Stock CenterBDSC:48441
genetic reagent (D. melanogaster)R10H10-Gal4Bloomington Drosophila Stock CenterBDSC:48445
genetic reagent (D. melanogaster)R11B09-Gal4Bloomington Drosophila Stock CenterBDSC:48288
genetic reagent (D. melanogaster)R11C01-Gal4Bloomington Drosophila Stock CenterBDSC:49240
genetic reagent (D. melanogaster)R14F05-Gal4Bloomington Drosophila Stock CenterBDSC:49257
genetic reagent (D. melanogaster)R16C05-Gal4Bloomington Drosophila Stock CenterBDSC:48718
genetic reagent (D. melanogaster)R18H11-Gal4Bloomington Drosophila Stock CenterBDSC:48832
genetic reagent (D. melanogaster)R19B09-Gal4Bloomington Drosophila Stock CenterBDSC:48840
genetic reagent (D. melanogaster)R19G10-Gal4Bloomington Drosophila Stock CenterBDSC:47887
genetic reagent (D. melanogaster)R20A02-Gal4Bloomington Drosophila Stock CenterBDSC:48870
genetic reagent (D. melanogaster)R20E05-Gal4Bloomington Drosophila Stock CenterBDSC:48898
genetic reagent (D. melanogaster)R21H04-Gal4Bloomington Drosophila Stock CenterBDSC:48958
genetic reagent (D. melanogaster)R23E10-Gal4Bloomington Drosophila Stock CenterBDSC:49032
genetic reagent (D. melanogaster)R25G04-Gal4Bloomington Drosophila Stock CenterBDSC:49136
genetic reagent (D. melanogaster)R26D11-Gal4Bloomington Drosophila Stock CenterBDSC:49323
genetic reagent (D. melanogaster)R27A05-Gal4Bloomington Drosophila Stock CenterBDSC:49208
genetic reagent (D. melanogaster)R30G08-Gal4Bloomington Drosophila Stock CenterBDSC:48101
genetic reagent (D. melanogaster)R32G08-Gal4Bloomington Drosophila Stock CenterBDSC:49729
genetic reagent (D. melanogaster)R32H03-Gal4Bloomington Drosophila Stock CenterBDSC:49733
genetic reagent (D. melanogaster)R34C05-Gal4Bloomington Drosophila Stock CenterBDSC:49778
genetic reagent (D. melanogaster)R43D05-Gal4Bloomington Drosophila Stock CenterBDSC:41259
genetic reagent (D. melanogaster)R44B02-Gal4Bloomington Drosophila Stock CenterBDSC:50199
genetic reagent (D. melanogaster)R45B03-Gal4Bloomington Drosophila Stock CenterBDSC:50221
genetic reagent (D. melanogaster)R46E11-Gal4Bloomington Drosophila Stock CenterBDSC:50272
genetic reagent (D. melanogaster)R47A08-Gal4Bloomington Drosophila Stock CenterBDSC:50288
genetic reagent (D. melanogaster)R50C11-Gal4Bloomington Drosophila Stock CenterBDSC:38742
genetic reagent (D. melanogaster)R50H05-Gal4Bloomington Drosophila Stock CenterBDSC:38764
genetic reagent (D. melanogaster)R51H05-Gal4Bloomington Drosophila Stock CenterBDSC:41275
genetic reagent (D. melanogaster)R54D11-Gal4Bloomington Drosophila Stock CenterBDSC:41279
genetic reagent (D. melanogaster)R57C10-Gal4Bloomington Drosophila Stock CenterBDSC:39171
genetic reagent (D. melanogaster)R57F07-Gal4Bloomington Drosophila Stock CenterBDSC:46389
genetic reagent (D. melanogaster)R61G12-Gal4Bloomington Drosophila Stock CenterBDSC:41286
genetic reagent (D. melanogaster)R64C04-Gal4Bloomington Drosophila Stock CenterBDSC:39296
genetic reagent (D. melanogaster)R64C10-Gal4Bloomington Drosophila Stock CenterBDSC:39301
genetic reagent (D. melanogaster)R65C07-Gal4Bloomington Drosophila Stock CenterBDSC:39344
genetic reagent (D. melanogaster)R65C11-Gal4Bloomington Drosophila Stock CenterBDSC:39347
genetic reagent (D. melanogaster)R66B05-Gal4Bloomington Drosophila Stock CenterBDSC:39389
genetic reagent (D. melanogaster)R70F10-Gal4Bloomington Drosophila Stock CenterBDSC:39545
genetic reagent (D. melanogaster)R70G01-Gal4Bloomington Drosophila Stock CenterBDSC:39546
genetic reagent (D. melanogaster)R78G02-Gal4Bloomington Drosophila Stock CenterBDSC:40010
genetic reagent (D. melanogaster)R85A11-Gal4Bloomington Drosophila Stock CenterBDSC:40415
genetic reagent (D. melanogaster)R86H08-Gal4Bloomington Drosophila Stock CenterBDSC:40471
genetic reagent (D. melanogaster)R91A01-Gal4Bloomington Drosophila Stock CenterBDSC:40569
genetic reagent (D. melanogaster)R95E11-Gal4Bloomington Drosophila Stock CenterBDSC:40711
genetic reagent (D. melanogaster)RNAi-acj6Bloomington Drosophila Stock CenterBDSC:29335
genetic reagent (D. melanogaster)RNAi-AkhBloomington Drosophila Stock CenterBDSC:27031
genetic reagent (D. melanogaster)RNAi-CryBloomington Drosophila Stock CenterBDSC:51033
genetic reagent (D. melanogaster)RNAi-CrzBloomington Drosophila Stock CenterBDSC:25999
genetic reagent (D. melanogaster)RNAi-CrzBloomington Drosophila Stock CenterBDSC:26017
genetic reagent (D. melanogaster)RNAi-CrzRBloomington Drosophila Stock CenterBDSC:42751
genetic reagent (D. melanogaster)RNAi-DATBloomington Drosophila Stock CenterBDSC:31256
genetic reagent (D. melanogaster)RNAi-DATBloomington Drosophila Stock CenterBDSC:50619
genetic reagent (D. melanogaster)RNAi-DDCBloomington Drosophila Stock CenterBDSC:27030
genetic reagent (D. melanogaster)RNAi-DDCBloomington Drosophila Stock CenterBDSC:51462
genetic reagent (D. melanogaster)RNAi-Dh31Bloomington Drosophila Stock CenterBDSC:41957
genetic reagent (D. melanogaster)RNAi-Dh44Bloomington Drosophila Stock CenterBDSC:25804
genetic reagent (D. melanogaster)RNAi-forBloomington Drosophila Stock CenterBDSC:21592
genetic reagent (D. melanogaster)RNAi-forBloomington Drosophila Stock CenterBDSC:31698
genetic reagent (D. melanogaster)RNAi-LkBloomington Drosophila Stock CenterBDSC:25936
genetic reagent (D. melanogaster)RNAi-LkRBloomington Drosophila Stock CenterBDSC:25836
genetic reagent (D. melanogaster)RNAi-Nplp2Bloomington Drosophila Stock CenterBDSC:53967
genetic reagent (D. melanogaster)RNAi-Nplp2Bloomington Drosophila Stock CenterBDSC:54041
genetic reagent (D. melanogaster)RNAi-OambBloomington Drosophila Stock CenterBDSC:31171
genetic reagent (D. melanogaster)RNAi-OambBloomington Drosophila Stock CenterBDSC:31233
genetic reagent (D. melanogaster)RNAi-Oct-TyrBloomington Drosophila Stock CenterBDSC:28332
genetic reagent (D. melanogaster)RNAi-OctAlpha2RBloomington Drosophila Stock CenterBDSC:50678
genetic reagent (D. melanogaster)RNAi-OctBeta1RBloomington Drosophila Stock CenterBDSC:31106
genetic reagent (D. melanogaster)RNAi-OctBeta1RBloomington Drosophila Stock CenterBDSC:31107
genetic reagent (D. melanogaster)RNAi-OctBeta1RBloomington Drosophila Stock CenterBDSC:50701
genetic reagent (D. melanogaster)RNAi-OctBeta1RBloomington Drosophila Stock CenterBDSC:58179
genetic reagent (D. melanogaster)RNAi-OctBeta2RBloomington Drosophila Stock CenterBDSC:34673
genetic reagent (D. melanogaster)RNAi-OctBeta2RBloomington Drosophila Stock CenterBDSC:50580
genetic reagent (D. melanogaster)RNAi-OctBeta3RBloomington Drosophila Stock CenterBDSC:31108
genetic reagent (D. melanogaster)RNAi-PdfBloomington Drosophila Stock CenterBDSC:25802
genetic reagent (D. melanogaster)RNAi-pleBloomington Drosophila Stock CenterBDSC:25796
genetic reagent (D. melanogaster)RNAi-pleBloomington Drosophila Stock CenterBDSC:65875
genetic reagent (D. melanogaster)RNAi-pleBloomington Drosophila Stock CenterBDSC:76062
genetic reagent (D. melanogaster)RNAi-pleBloomington Drosophila Stock CenterBDSC:76069
genetic reagent (D. melanogaster)RNAi-ppk25Bloomington Drosophila Stock CenterBDSC:27088
genetic reagent (D. melanogaster)RNAi-ProcRBloomington Drosophila Stock CenterBDSC:29414
genetic reagent (D. melanogaster)RNAi-ProcRBloomington Drosophila Stock CenterBDSC:29570
genetic reagent (D. melanogaster)RNAi-ptp69DBloomington Drosophila Stock CenterBDSC:29462
genetic reagent (D. melanogaster)RNAi-ShakBBloomington Drosophila Stock CenterBDSC:27292
genetic reagent (D. melanogaster)RNAi-SifABloomington Drosophila Stock CenterBDSC:29428
genetic reagent (D. melanogaster)RNAi-SifABloomington Drosophila Stock CenterBDSC:60484
genetic reagent (D. melanogaster)RNAi-TbhBloomington Drosophila Stock CenterBDSC:27667
genetic reagent (D. melanogaster)RNAi-TbhBloomington Drosophila Stock CenterBDSC:67968
genetic reagent (D. melanogaster)RNAi-Tdc2Bloomington Drosophila Stock CenterBDSC:25871
genetic reagent (D. melanogaster)RNAi-TkBloomington Drosophila Stock CenterBDSC:25800
genetic reagent (D. melanogaster)RNAi-TkR86CBloomington Drosophila Stock CenterBDSC:31884
genetic reagent (D. melanogaster)RNAi-TkR99DBloomington Drosophila Stock CenterBDSC:27513
genetic reagent (D. melanogaster)RNAi-trhBloomington Drosophila Stock CenterBDSC:25842
genetic reagent (D. melanogaster)RNAi-tutlBloomington Drosophila Stock CenterBDSC:54850
genetic reagent (D. melanogaster)RNAi-TyrRBloomington Drosophila Stock CenterBDSC:25857
genetic reagent (D. melanogaster)RNAi-TyrRBloomington Drosophila Stock CenterBDSC:57296
genetic reagent (D. melanogaster)RNAi-TyrRIIBloomington Drosophila Stock CenterBDSC:27670
genetic reagent (D. melanogaster)RNAi-TyrRIIBloomington Drosophila Stock CenterBDSC:64964
genetic reagent (D. melanogaster)ry506Bloomington Drosophila Stock CenterBDSC:225
genetic reagent (D. melanogaster)RyaR-Bloomington Drosophila Stock CenterBDSC:84571
genetic reagent (D. melanogaster)shakB-Gal4Bloomington Drosophila Stock CenterBDSC:51633
genetic reagent (D. melanogaster)SifA-Gal4Bloomington Drosophila Stock CenterBDSC:84690
genetic reagent (D. melanogaster)sNPF-Bloomington Drosophila Stock CenterBDSC:84574
genetic reagent (D. melanogaster)SS00078-Gal4Janelia Research CenterJRC:SS00078
genetic reagent (D. melanogaster)SS00090-Gal4Janelia Research CenterJRC:SS00090
genetic reagent (D. melanogaster)SS00097-Gal4Janelia Research CenterJRC:SS00097
genetic reagent (D. melanogaster)SS00117-Gal4Janelia Research CenterJRC:SS00117
genetic reagent (D. melanogaster)SS01566-Gal4Janelia Research CenterJRC:SS01566
genetic reagent (D. melanogaster)SS02214-Gal4Janelia Research CenterJRC:SS02214
genetic reagent (D. melanogaster)SS02216-Gal4Janelia Research CenterJRC:SS02216
genetic reagent (D. melanogaster)SS02255-Gal4Janelia Research CenterJRC:SS02255
genetic reagent (D. melanogaster)SS02391-Gal4Janelia Research CenterJRC:SS02391
genetic reagent (D. melanogaster)SS27853-Gal4Janelia Research CenterJRC:SS27853
genetic reagent (D. melanogaster)SS50464-Gal4Janelia Research CenterJRC:SS50464
genetic reagent (D. melanogaster)SS52578-Gal4Janelia Research CenterJRC:SS52578
genetic reagent (D. melanogaster)Tbh-Bloomington Drosophila Stock CenterBDSC:56660
genetic reagent (D. melanogaster)Tdc-Gal4Bloomington Drosophila Stock CenterBDSC:9313
genetic reagent (D. melanogaster)tim-Gal4Bloomington Drosophila Stock CenterBDSC:80941
genetic reagent (D. melanogaster)Trh-Bloomington Drosophila Stock CenterBDSC:10531
genetic reagent (D. melanogaster)Trh-Gal4Bloomington Drosophila Stock CenterBDSC:38388
genetic reagent (D. melanogaster)Trh-Gal4Bloomington Drosophila Stock CenterBDSC:38389
genetic reagent (D. melanogaster)tutl-Gal4Bloomington Drosophila Stock CenterBDSC:63344
genetic reagent (D. melanogaster)tutl-Gal4/CyO;Cha-Gal80Derived from BDSC:63344 and Cha-Gal80
genetic reagent (D. melanogaster)tutl1/CyOKendal Broadie
(Bodily et al., 2001)
genetic reagent (D. melanogaster)TyrR-Bloomington Drosophila Stock CenterBDSC:27797
genetic reagent (D. melanogaster)TyrRII-Bloomington Drosophila Stock CenterBDSC:23837
genetic reagent (D. melanogaster)UAS-CsChrimsonBloomington Drosophila Stock Center; Klapoetke et al., 2014BDSC:55135
genetic reagent (D. melanogaster)UAS-DTIBloomington Drosophila Stock CenterBDSC:25039
genetic reagent (D. melanogaster)UAS-eGFP-Kir2.1.FRT.mCherryDavid Anderson; Watanabe et al., 2017
genetic reagent (D. melanogaster)UAS-hidBloomington Drosophila Stock CenterBDSC:65403
genetic reagent (D. melanogaster)UAS-Kir2.1Jess Kanwal; Baines et al., 2001
genetic reagent (D. melanogaster)UAS-mcd8GFPBloomington Drosophila Stock CenterBDSC:32185
genetic reagent (D. melanogaster)UAS-mCherry.FRT.eGFP-Kir2.1David Anderson; Watanabe et al., 2017
genetic reagent (D. melanogaster)UAS-NiPP1Bloomington Drosophila Stock CenterBDSC:23711
genetic reagent (D. melanogaster)UAS-PdfRg/CyO; UAS-Cas9/TM6BMatthias Schlichting; Schlichting et al., 2019
genetic reagent (D. melanogaster)UAS-syt-eGFP, DenMarkBloomington Drosophila Stock CenterBDSC:33064
genetic reagent (D. melanogaster)UAS-TNT-CBloomington Drosophila Stock CenterBDSC:28996
genetic reagent (D. melanogaster)UAS-TNT-EBloomington Drosophila Stock CenterBDSC:28837
genetic reagent (D. melanogaster)UAS-TNT-GBloomington Drosophila Stock CenterBDSC:28838
genetic reagent (D. melanogaster)UAS-TrpA1Bloomington Drosophila Stock CenterBDSC:26263
genetic reagent (D. melanogaster)VT002215-Gal4Janelia Research CenterJRC:VT002215
genetic reagent (D. melanogaster)VTDh44-Gal4/TM3, SbVT039046
(via Daniel Cavanaugh)
genetic reagent (D. melanogaster)w; Aug21-Gal4, UAS-GFP/CyODerived from C(1)Dxyfv(X^X)/Y; Aug21-Gal4, UAS-GFP/CyO
otherAcetoneSigmaCat#: 179124Vehicle for Methoprene and Prococene I
otherFluvastatinSigmaCat: PHR1620Mevalonate synthesis pathway inhibitor
otherHoechst 33342Thermo FisherCat#: H-3570IF(1:1000)
otherMethopreneSigmaCat#: 33375JH analog
otherPrecocene ISigmaCat#: 195855CA inhibitor
otherPyriproxyfenSigmaCat#: 34174JH analog
otherRhoBSigmaCat#: R6626(1.44 mg/mL)
peptide, recombinant proteinPhalloidinThermo FisherCat#: A-12380IF(1:400)
software, algorithmMARGOWerkhoven et al., 2019
strain (Entomophthora muscae)Entomophthora muscaeElya et al., 2018ARSEF #13514

Additional files

Supplementary file 1

Fly strains tested in summit inactivation screen.

Genotypes are abbreviated for lines deposited at stock centers, for clarity. Stock centers are as follows: BDSC = Bloomington Drosophila Stock Center; KDSC = Kyoto Drosophila Stock Center; JRC = Janelia Research Campus. Functional/morphological annotations for the summit screen are abbreviated as follows: AM = AMMC; Ar = arousal; Ci = circadian; CX = central complex; Gr = gravitaxis; SO = subesophageal ganglion; MB = mushroom body; NM = neuromodulator & neurotransmitter; NP = neuropeptide; PI = pars intercerebralis.

https://cdn.elifesciences.org/articles/85410/elife-85410-supp1-v2.docx
Supplementary file 2

Genotypes of flies in manuscript figures.

Genotypes for deposited lines are abbreviated for clarity (i.e. interrupted alleles are designated [-], most y and w alleles have been omitted). Stock centers are as follows: BDSC = Bloomington Drosophila Stock Center; KDSC = Kyoto Drosophila Stock Center; JRC = Janelia Research Campus.

https://cdn.elifesciences.org/articles/85410/elife-85410-supp2-v2.docx
Supplementary file 3

Metabolomics data for both manual and classifier-assisted experiments.

Sheets with prefix ‘All_’ contain all of the data from the indicated metabolomics experiment. Sheet with prefix ‘Overlap_’ contains data for compounds that were observed in both experiments (compounds whose molecular weight corresponded within five parts per million [ppm]). Column headers ending in (M) indicate results from the manually-staged experiment; (C) from the classifier-staged experiments. Annotations for columns A, B, C, K, and N are as follows (with values of 1 or TRUE indicating the condition is met, 0 or FALSE that the condition is not met): ‘Significant’ = significantly different between NS and S across both experiments; ‘Infected-specific’ = compound only present in NS and S, but not C, samples, per manual chromatogram inspection; ‘Summiting-specific’ = compound only present in S, but not NS or C, samples, per manual chromatogram inspections; ‘Same tentative formula?’ = predicted formulae for given compound match exactly across experiments; ‘Same sign?’ = log2 fold change of compound abundance between S and NS samples is consistently positive or negative across experiments. Abbreviations: S = summiting, NS = exposed but non-summiting, C = unexposed control.

https://cdn.elifesciences.org/articles/85410/elife-85410-supp3-v2.xlsx
MDAR checklist
https://cdn.elifesciences.org/articles/85410/elife-85410-mdarchecklist1-v2.docx

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Carolyn Elya
  2. Danylo Lavrentovich
  3. Emily Lee
  4. Cassandra Pasadyn
  5. Jasper Duval
  6. Maya Basak
  7. Valerie Saykina
  8. Benjamin de Bivort
(2023)
Neural mechanisms of parasite-induced summiting behavior in ‘zombie’ Drosophila
eLife 12:e85410.
https://doi.org/10.7554/eLife.85410